M.J. Tilby
Impact in
-
- HER2/EGFR in Cancer Research
Papers in
-
- Cell death mechanisms and regulation 3
- Retinoids in leukemia and cellular processes 3
- Glycosylation and Glycoproteins Research 1
-
- Multiple Myeloma Research and Treatments 2
- Chronic Myeloid Leukemia Treatments 1
- Hematopoietic Stem Cell Transplantation 1
- Co-authors
- Andrew G. Hall (1 shared paper)Daniel Hochhauser (1 shared paper)Jaishree Bhosle (1 shared paper)John A. Hartley (1 shared paper)Mauro Piacentini (3 shared papers)Archie J. Malcolm (3 shared papers)Marco Ranalli (3 shared papers)Gerry Melino (3 shared papers)
- Journals
- Biochemical Pharmacology (1 paper)European Journal of Cancer (1 paper)Chemico-Biological Interactions (1 paper)Annals of Oncology (1 paper)Blood Reviews (1 paper)
- Partner nations
- United KingdomItalyNetherlands
In The Last Decade
M.J. Tilby
8 papers receiving 324 citations
Peers
Comparison fields: 5 of 71
- Oncology 86
- Hematology 30
- Cancer Research 34
- Molecular Biology 162
- Pathology and Forensic Medicine 35
Countries citing papers authored by M.J. Tilby
This map shows the geographic impact of M.J. Tilby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.J. Tilby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.J. Tilby more than expected).
Fields of papers citing papers by M.J. Tilby
This network shows the impact of papers produced by M.J. Tilby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.J. Tilby. The network helps show where M.J. Tilby may publish in the future.
Co-authors
The 25 scholars most cited alongside M.J. Tilby, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 142 | |
| 2 | 2000 | 51 | |
| 3 | 2009 | 47 | |
| 4 | 1990 | 21 | |
| 5 | 2000 | 19 | |
| 6 | 1993 | 18 | |
| 7 | 2004 | 18 | |
| 8 | 1999 | 18 | |
| 9 | 2000 | 0 |
About M.J. Tilby
M.J. Tilby is a scholar working on Molecular Biology, Hematology, Neurology, Oncology and Ecology, Evolution, Behavior and Systematics, having authored 9 papers that have together received 334 indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (3 papers), Retinoids in leukemia and cellular processes (3 papers), Multiple Myeloma Research and Treatments (2 papers), Neuroblastoma Research and Treatments (2 papers), Chronic Myeloid Leukemia Treatments (1 paper), Glycosylation and Glycoproteins Research (1 paper), Acute Lymphoblastic Leukemia research (1 paper) and Hematopoietic Stem Cell Transplantation (1 paper). The work is most often cited by research in Oncology (86 citations), Hematology (30 citations), Cancer Research (34 citations), Molecular Biology (162 citations) and Pathology and Forensic Medicine (35 citations). M.J. Tilby has collaborated with scholars based in United Kingdom, Italy and Netherlands. Frequent co-authors include Andrew G. Hall, Daniel Hochhauser, Jaishree Bhosle, John A. Hartley, Mauro Piacentini, Archie J. Malcolm, Marco Ranalli, Gerry Melino, Francesca Bernassola and Andy D.J. Pearson. Their work appears in journals such as Biochemical Pharmacology, European Journal of Cancer, Chemico-Biological Interactions, Annals of Oncology and Blood Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.